“I Fully Believe That EXOGEN Was a Total Gamechanger for Me.”

Severely injured in a car accident, Angela Jones faced one particularly grim prognosis. Her right heel had been so badly crushed that, at one point, doctors told her they may need to amputate the foot. Angela began to feel more hopeful after reconstructive surgery on the heel, and even more so after a friend told her about EXOGEN. After consulting with her orthopaedic surgeon, Angela began using EXOGEN—and the results were dramatic.

This video story is representative of a US FDA-approved indication for the use of EXOGEN.

Disclaimer: Information presented in patient testimonials is representative of a specific patient experience only and does not constitute medical advice.


Summary of Indications for Use

EXOGEN is indicated for the non-invasive treatment of osseous defects (excluding vertebra and skull) that includes the treatment of delayed unions, nonunions,* stress fractures and joint fusion. EXOGEN is also indicated for the acceleration of fresh fracture heal time, repair following osteotomy, repair in bone transport procedures and repair in distraction osteogenesis procedures.

There are no known contraindications for the EXOGEN device. Safety and effectiveness have not been established for individuals lacking skeletal maturity, pregnant or nursing women, patients with cardiac pacemakers, on fractures due to bone cancer, or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel.

Full prescribing information can be found in product labeling, at https://www.exogen.com/, or by calling Bioventus Customer Service.

*A nonunion is considered to be established when the fracture site shows no visibly progressive signs of healing.